Drug
Ach 0143102
Ach 0143102: highest development phase Phase 1, developed by Alexion. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| ACH-0143102 NCT01700179 | Phase 1 | Chronic Hepatitis C Infection |
Latest
No recent events.
Follow Ach 0143102 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.